Publications : Details
Medabon for Medical Abortion: Resource Materials for Health Care Providers and Program Managers
Medical abortion—an approach that uses medication rather than surgical intervention to end a pregnancy—may be one way to help women get the safe services they need. Until recently, the two medications most widely approved for safe and effective medical abortion (mifepristone and misoprostol) were packaged and licensed separately. They are now licensed and packaged together as one product: Medabon®. This information package helps health care providers, program managers, policymakers, the media, and women understand the new product.
Corporate author(s): Concept Foundation, Ipas, PATH
Publication date: August 2009
Available materials
English
(Located at www.medabon.info)
571 KB PDF
(Located at www.medabon.info)
293 KB PDF
(Located at www.medabon.info)
355 KB PDF
(Located at www.medabon.info)
508 KB PDF
(Located at www.medabon.info)
359 KB PDF
(Located at www.medabon.info)
342 KB PDF
(Located at www.medabon.info)
2.4 MB PDF
(Located at www.medabon.info)
322 KB PDF
(Located at www.medabon.info)
447 KB PDF
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Region: Global
See also: Reproductive health > Safe abortion
For more information…
Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA
Facebook
Twitter
Blog